Search Results - "RICCA, C"

Refine Results
  1. 1

    A first combined electrochemical and modelling strategy on composite carbonate/oxide electrolytes for hybrid fuel cells by Ricca, C., Albin, V., Labat, F., Adamo, C., Cassir, M., Ringuedé, A.

    Published in International journal of hydrogen energy (02-11-2016)
    “…Carbonate/oxide composites are very promising electrolyte materials in hybrid fuel cells which could operate at lower temperature than the usual Molten…”
    Get full text
    Journal Article
  2. 2

    Design Modeling and Sizing Equations of V-shape IPM Motors by Di Gerlando, A., Ricca, C.

    “…The paper develops the model of a V-shape IPM motor for automotive applications. The approach, design oriented, considers saturation and cross-coupling, by…”
    Get full text
    Conference Proceeding
  3. 3
  4. 4

    Analytical Design of a High Torque Density In-Wheel YASA AFPM Motor by Gerlando, A. Di, Foglia, G., Ricca, C.

    “…The following paper presents an analytical design approach of a Yokeless and Segmented Armature Axial Flux Permanent Magnet (YASA AFPM) in-wheel motor for…”
    Get full text
    Conference Proceeding
  5. 5

    Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells by Manne, V, Yan, N, Carboni, J M, Tuomari, A V, Ricca, C S, Brown, J G, Andahazy, M L, Schmidt, R J, Patel, D, Zahler, R

    Published in Oncogene (04-05-1995)
    “…We describe the biological properties of a new class of potent farnesyltransferase (FT) inhibitors designed as bisubstrate analog inhibitors. These inhibitors…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype by NING YAN, RICCA, C, GLOVER, T, SEIZINGER, B. R, MANNE, V, FLETCHER, J

    Published in Cancer research (Chicago, Ill.) (15-08-1995)
    “…Neurofibromatosis type I (NF1) is a hereditary tumor and developmental disorder whose defective gene was cloned previously. The protein product of the NF1…”
    Get full text
    Journal Article
  11. 11

    Potent, Cell Active, Non-Thiol Tetrapeptide Inhibitors of Farnesyltransferase by Hunt, John T, Lee, Ving G, Leftheris, Katerina, Seizinger, Bernd, Carboni, Joan, Mabus, John, Ricca, Carol, Yan, Ning, Manne, Veeraswamy

    Published in Journal of medicinal chemistry (19-01-1996)
    “…All previously reported CAAX-based farnesyltransferase inhibitors contain a thiol functionality. We report that attachment of the 4-imidazolyl group, via 1-,…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    3-Imidazolylmethylaminophenylsulfonyltetrahydroquinolines, a novel series of farnesyltransferase inhibitors by DING, C. Z, HUNT, J. T, RICCA, C, MANNE, V

    Published in Bioorganic & medicinal chemistry letters (07-02-2000)
    “…Design, synthesis and structure-activity relationship of a series of 3-imidazolylmethylaminophenylsulfonyltetrahydroquinolines as farnesyltransferase…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Phosphinyl acid-based bisubstrate analog inhibitors of ras farnesyl protein transferase by PATEL, D. V, GORDON, E. M, RICCA, C, ROBINSON, S, SEIZINGER, B. R, TUOMARI, A. V, MANNE, V, SCHMIDT, R. J, WELLER, H. N, YOUNG, M. G, ZAHLER, R, BARBACID, M, CARBONI, J. M, GULLO-BROWN, J. L, HUNIHAN, L

    Published in Journal of medicinal chemistry (03-02-1995)
    “…The rational design, synthesis, and biological activity of phosphonyl- and phosphinyl-linked bisubstrate analog inhibitors of the enzyme Ras farnesyl protein…”
    Get full text
    Journal Article